Treatment

HRS9531 clinical trials

Active studies that list HRS9531 as an intervention or treatment.

3active studies

2recruiting now

1countries represented

1largest site network

Current studies

Status and location data reflect the registry snapshot built 2026-09-08. Verify the original record before contacting a site.

Recruiting nowPhase 3

Subjects With Moderate-to-severe OSA and Obesity Who Are on PAP TherapyCondition

HRS9531, PlaceboTreatment

China1 locations

Fujian Shengdi Pharmaceutical Co., Ltd.Sponsor

Updated 2026-01-26 · NCT06994650See eligibility →

Recruiting nowPhase 3

Bstructive Sleep Apnea (OSA) and ObesityCondition

HRS9531, HRS9531placeboTreatment

China1 locations

Fujian Shengdi Pharmaceutical Co., Ltd.Sponsor

Updated 2025-11-17 · NCT06974851See eligibility →

Active, not recruitingPhase 2

Heart Failure With Preserved Ejection FractionCondition

HRS9531, PlaceboTreatment

China1 locations

Fujian Shengdi Pharmaceutical Co., Ltd.Sponsor

Updated 2025-11-24 · NCT06391710See eligibility →

How current is this page?

The page is rebuilt from the public registry feed. Each trial card shows the registry update date. Recruitment can still change between builds.

Does appearing here mean I qualify?

No. These pages are discovery indexes. Only a study team can confirm eligibility after reviewing the complete protocol criteria.